LDC203974(IMT1B)

  Cat. No.:  DC39817   Featured
LDC203974(IMT1B)
Chemical Structure
2304621-06-3
For research use only. We do not sell to patients.
We match the best price and quality on market.
Email:order@dcchemicals.com  sales@dcchemicals.com
Tel:+86-021-58447131
We are official vendor of:
  • 20
  • 19
  • 18
  • 17
  • 16
  • 15
  • 14
  • 12
  • 11
  • 10
  • 9
  • 8
  • 13
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
More than 5000 active chemicals with high quality for research!
Field of application
LDC203974(IMT1B) is a highly specific inhibitor of human mitochondrial RNA polymerase (POLRMT) with improved pharmacokinetic profiles than LDC195943(IMT1).
Cas No.: 2304621-06-3
Chemical Name: 3-​Piperidinecarboxylic acid, 1-​[(2R)​-​2-​[[4-​(2-​chloro-​4-​fluorophenyl)​-​2-​oxo-​2H-​1-​benzopyran-​7-​yl]​oxy]​-​1-​oxopropyl]​-​, (3S)​-
Synonyms: LDC203974;LDC 203974;LDC-203974;IMT1B,IMT1-B IMT1 B
SMILES: C1(C(Cl)=CC(F)=CC=1)C1=CC(=O)OC2=C1C=CC(=C2)O[C@@H](C(=O)N1CCC[C@H](C(=O)O)C1)C
Formula: C24H21ClFNO6
M.Wt: 473.88
Purity: >99%
Sotrage: 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Publication: Small-molecule inhibitors of human mitochondrial DNA transcription-Nature,Published: 16 December 2020
Description:
In Vivo:
In Vitro:
References:
Kinase Assay:
Cell Assay:
Animal Administration:
References:
MSDS
TITLE DOWNLOAD
MSDS_25860_DC39817_2304621-19-8
COA
LOT NO. DOWNLOAD
Cat. No. Product name Field of application
DC52050 Lats-IN-1(TRULI ) Lats-IN-1 is a potent and ATP-competitive inhibitor of Lats1 and Lats2 kinases. Lats-IN-1 promotes Yap-dependent proliferation in postmitotic mammalian tissues.
DC52035 BAR501 Impurity BAR501 impurity is an impurity found in the preparation of BAR501 that acts as an agonist of the G protein-coupled bile acid-activated receptor (GP-BAR1). BAR501 impurity (10 µM) induces a 150% increase in luciferase activity in a GP-BAR1 reporter gene assay.
DC52033 RORγt Inverse agonist 6 RORγt Inverse agonist 6 (compound 43) is a RORγt inverse agonist for the study of Th17-driven autoimmune diseases. RORγt Inverse agonist 6 (compound 43) suppresses IL-17A gene expression by IL-23 stimulation in vivo.
DC51019 AST5902 AST5902 is the active metabolite of Alflutinib.
DC51012 IXA4 IXA4 is the most selective for the IRE1–XBP1s signaling pathway.IXA4 selectively activate IRE1–XBP1s signaling and reduces secretion of APP through IRE1 activation.
DC51011 IXA6 IXA6 is a novel small molecule compound of inducing IRE1 RNase activity.
DC51005 BMS986313 BMS-986313 is a tricyclic-carbocyclic RORγt inverse agonist and shows potent GaL4-Luc reporter(GAL4) and human whole blood (hWB) activity (EC50s of 3.6 nM and 50 nM, respectively.
DC51003 BMS986224 BMS-986224 is a potent and selective apelin receptor (APJ) agonist with Ki of 0.074 nM, exhibiting similar receptor binding and signaling profile to (Pyr1) apelin-13.
DC51001 Sisunatovir HCl Sisunatovir, also known as RV521, is a highly potent fusion inhibitor with efficacy against a panel of clinical isolates of RSV-A and RSV-B viruses. RV521 exhibited a mean IC50 of 1.2 nM against a panel of RSV A and B laboratory strains and clinical isolates with antiviral efficacy in the Balb/C mouse model of RSV infection. Oral bioavailability in preclinical species ranged from 42 to >100% with evidence of highly efficient penetration into lung tissue. In healthy adult human volunteers experimentally infected with RSV, a potent antiviral effect was observed with a significant reduction in viral load and symptoms compared to placebo.
DC51000 Sisunatovir (Synonyms: RV521) Sisunatovir (RV521), an orally available inhibitor of the RSV fusion (RSV-F) protein, exhibits potent efficacy against a panel of clinical isolates of RSV-A and RSV-B viruses, with IC50s of 1.4 nM and 1.0 nM, respectively.